Royalty Pharma
RPRX
$28.07
Share price
-1.09%
Change (1 day)
-18.23%
Change (1 year)
Categories
P/S ratio for Royalty Pharma (RPRX)
P/S ratio as of May 2024 (TTM): 7.12
According to Royalty Pharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 7.12239. At the end of 2023 the company had a P/S ratio of 7.15.
P/S ratio history for Royalty Pharma from 2020 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 7.15 | -8.2% |
| 2022 | 7.79 | 4.23% |
| 2021 | 7.48 | -18.32% |
| 2020 | 9.15 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 4.51 | -36.66% | 🇺🇸 USA |
 Eli Lilly LLY | 20.2 | 183.72% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | 2.84 | -60.08% | 🇺🇸 USA |